News & Updates

Show Multimedia Only
Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB

Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB

16 Oct 2024 byJairia Dela Cruz

In the treatment of patients with rifampicin-resistant tuberculosis (TB), two bedaquiline-containing regimens, namely a 9-month all-oral regimen and a shorter 6-month regimen with 8 weeks of aminoglycoside, maintains superior efficacy to a 9-month injectable regimen through 132 weeks, according to long-term data from the STREAM 2 trial.

16 Oct 2024
Depression, anxiety tied to intragastric balloon intolerance, early removal

Depression, anxiety tied to intragastric balloon intolerance, early removal

16 Oct 2024 byStephen Padilla

Intragastric balloons (IGBs) are a less-invasive alternative to metabolic bariatric surgery (MBS) in the treatment of obesity and its complications, but many Asians suffer intolerance and have a higher rate of early balloon removal relative to Caucasians, reports a Singapore study. Moreover, both depression and anxiety are associated with early IGB removal.

16 Oct 2024